| Target Price | $17.34 |
| Price | $0.45 |
| Potential |
3,753.33%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Eagle Pharmaceuticals, Inc. 2026 .
The average Eagle Pharmaceuticals, Inc. target price is $17.34.
This is
3,753.33%
register free of charge
$17.85
3,866.67%
register free of charge
$17.17
3,715.56%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Eagle Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Eagle Pharmaceuticals, Inc. stock has an average upside potential 2026 of
3,753.33%
register free of charge
|
| Dec '22 |
2023 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.73 | 4.67 |
| 513.64% | 71.06% | |
| P/E | 0.10 | |
| EV/Sales | 0.23 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


